Purpose
To investigate whether antihypertensive treatment with the angiotensin converting enzyme (ACE) inhibitor captopril may reduce
cardiovascular mortality and morbidity more than a therapeutic regimen which does not include an ACE inhibitor
References
The CAPPP Group: The Captopril Prevention Project: a prospective intervention trial of angiotensin converting
enzyme inhibition in the treatment of hypertension. The CAPPP Group. J Hypertens 1990, 8:985-990.
Hansson L: The Captopril Prevention Project (CAPPP): description and status. Am J Hypertens 1994, 7:82S-83S. |
Farmacêutica